Free Trial

argenex (ARGX) Financials

argenex logo
$807.55 +12.85 (+1.62%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$821.92 +14.37 (+1.78%)
As of 05/6/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for argenex

Annual Income Statements for argenex

This table shows argenex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-17 -22 -34 -76 181 -608 -817 -710 -295 833 1,292
Consolidated Net Income / (Loss)
-17 -22 -34 -76 181 -608 -408 -710 -295 833 1,292
Net Income / (Loss) Continuing Operations
-17 -22 -34 -76 -197 -650 -817 -716 -294 836 1,296
Total Pre-Tax Income
-17 -22 -33 -75 176 -605 -808 -735 -304 88 1,283
Total Operating Income
-17 -23 -35 -80 199 -478 -807 -762 -407 -62 1,132
Total Gross Profit
11 18 43 48 78 -126 39 373 1,165 1,977 3,863
Total Revenue
11 18 43 48 78 -126 39 403 1,283 2,204 4,314
Operating Revenue
11 18 43 48 78 -126 39 403 1,283 2,204 4,314
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00 29 118 227 451
Operating Cost of Revenue
- - - - - 0.00 0.00 29 118 227 451
Total Operating Expenses
28 41 77 127 277 519 846 1,135 1,571 2,039 2,731
Selling, General & Admin Expense
5.35 7.38 15 31 72 172 308 472 712 1,055 1,367
Research & Development Expense
22 33 62 96 221 371 581 663 859 983 1,364
Total Other Income / (Expense), net
0.12 0.08 1.50 4.23 6.99 -1.50 -0.95 27 103 150 151
Interest & Investment Income
- - 1.50 - - 6.46 3.63 28 107 158 163
Other Income / (Expense), net
0.12 0.08 0.00 4.23 6.99 - - -0.68 -4.41 -7.64 -12
Income Tax Expense
0.00 0.00 0.72 0.91 5.29 3.10 8.52 -20 -9.44 -748 -13
Basic Earnings per Share
- - - - $4.69 ($13.40) - ($13.05) ($5.16) $13.92 $21.08
Weighted Average Basic Shares Outstanding
15.73M 18.82M 24.61M 33.42M 38.62M 45.41M 51.08M 54.38M 57.17M 59.86M 61.88M
Diluted Earnings per Share
- - - - $4.69 ($13.40) - ($13.05) ($5.16) $12.78 $19.57
Weighted Average Diluted Shares Outstanding
15.73M 18.82M 24.61M 33.42M 38.62M 45.41M 51.08M 54.38M 57.17M 59.86M 61.88M
Weighted Average Basic & Diluted Shares Outstanding
15.73M 18.82M 24.61M 33.42M 38.62M 45.41M 51.08M 54.38M 57.17M 59.86M 61.30M

Quarterly Income Statements for argenex

No quarterly income statements for argenex are available.


Annual Cash Flow Statements for argenex

This table details how cash moves in and out of argenex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.21 54 375 328 52 779 1,149 1,279 1,225 57 -1,314
Net Cash From Operating Activities
0.21 11 -44 -62 152 776 -607 519 216 58 -1,307
Net Cash From Continuing Operating Activities
0.21 7.97 7.95 47 128 776 146 519 216 58 -1,307
Net Income / (Loss) Continuing Operations
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation Expense
0.21 0.34 0.51 0.54 2.38 3.67 5.09 4.58 5.63 7.25 13
Amortization Expense
0.01 0.01 0.01 0.02 0.04 0.25 0.78 100 106 10 15
Non-Cash Adjustments To Reconcile Net Income
0.00 3.00 5.17 22 46 810 168 679 233 212 -885
Changes in Operating Assets and Liabilities, net
- 4.62 2.26 25 80 -38 -28 -264 -129 -171 -451
Net Cash From Investing Activities
0.00 -0.85 -195 -123 833 0.00 -347 -0.84 -0.81 -1.80 -6.17
Net Cash From Continuing Investing Activities
0.00 -0.83 0.03 0.79 -41 0.00 -119 -0.84 -0.81 -1.80 -6.17
Purchase of Property, Plant & Equipment
- -0.91 -0.42 -0.78 -47 - -121 -0.84 -0.81 -1.80 -6.17
Net Cash From Financing Activities
0.00 47 367 280 734 0.00 1,121 761 1,197 0.00 0.00
Net Cash From Continuing Financing Activities
0.00 47 367 278 734 0.00 1,120 761 1,197 0.00 0.00
Issuance of Common Equity
- 48 394 293 756 - 1,091 761 1,197 0.00 0.00
Cash Interest Paid
- - - - - 0.40 - 0.85 0.21 0.39 0.90
Cash Interest Received
- - - - - 7.96 - 13 93 112 163

Quarterly Cash Flow Statements for argenex

No quarterly cash flow statements for argenex are available.


Annual Balance Sheets for argenex

This table presents argenex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
50 111 446 662 1,610 2,279 2,850 3,134 4,542 6,203 8,683
Total Current Assets
48 107 441 655 1,543 2,057 2,543 2,774 4,124 4,883 6,899
Cash & Equivalents
39 95 229 322 372 1,217 1,335 801 2,049 1,500 3,491
Accounts Receivable
1.47 2.07 3.41 3.30 32 6.98 38 276 497 904 1,647
Inventories, net
- - - 0.00 0.00 25 109 228 311 407 474
Prepaid Expenses
0.49 2.26 2.81 3.43 10 28 59 76 134 188 328
Other Current Assets
7.40 7.19 203 325 1,128 780 1,002 1,392 1,131 1,879 949
Plant, Property, & Equipment, net
0.27 0.81 0.81 0.94 9.18 12 16 0.00 23 44 48
Total Noncurrent Assets
0.01 1.23 0.17 0.35 49 190 259 296 272 1,157 1,623
Long-Term Investments
- - 0.00 - - 0.00 0.00 1.32 9.91 9.27 3.38
Intangible Assets
0.01 0.02 0.02 0.06 45 167 172 175 125 181 272
Noncurrent Deferred & Refundable Income Taxes
- - - 0.00 0.00 15 32 79 97 924 1,296
Other Noncurrent Operating Assets
0.00 1.21 0.15 0.29 3.62 7.82 55 41 40 42 52
Total Liabilities & Shareholders' Equity
50 111 446 662 1,610 2,279 2,850 3,134 4,542 6,203 8,683
Total Liabilities
9.44 45 31 46 430 605 316 321 445 704 1,360
Total Current Liabilities
9.44 34 29 46 180 328 301 302 423 670 1,320
Accounts Payable
4.94 13 18 42 96 275 293 296 414 650 1,267
Current Deferred & Payable Income Tax Liabilities
0.00 0.00 0.72 0.94 0.39 3.50 4.32 3.18 4.33 13 42
Other Current Liabilities
- - 0.00 0.00 2.22 3.48 3.51 3.42 4.65 6.53 11
Total Noncurrent Liabilities
0.00 11 1.75 0.01 250 277 15 18 22 34 39
Capital Lease Obligations
- - - - 5.10 6.18 7.96 9.01 15 33 36
Noncurrent Deferred & Payable Income Tax Liabilities
- - - 0.00 0.00 1.49 6.44 8.41 5.16 0.00 0.00
Noncurrent Employee Benefit Liabilities
0.00 0.00 0.03 0.01 0.07 0.16 0.42 0.87 1.45 1.80 3.09
Total Equity & Noncontrolling Interests
41 67 414 616 1,922 1,674 2,534 2,814 4,098 5,498 7,323
Total Preferred & Common Equity
41 67 414 616 1,180 1,674 2,534 2,814 4,098 5,498 7,323
Preferred Stock
89 133 517 771 1,506 2,339 3,463 4,310 5,651 5,949 6,187
Total Common Equity
-49 -66 -103 -155 416 -665 -929 -1,496 -1,554 -451 1,137
Common Stock
1.72 2.12 3.86 4.12 5.21 5.74 6.23 6.64 7.06 7.23 7.35
Retained Earnings
-56 -76 -121 -194 383 -992 -1,400 -2,110 -2,405 -1,572 -280
Other Equity Adjustments
5.05 7.89 14 35 28 321 465 607 844 1,114 1,409

Quarterly Balance Sheets for argenex

No quarterly balance sheets for argenex are available.


Annual Metrics And Ratios for argenex

This table displays calculated financial ratios and metrics derived from argenex's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 61,883,306.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 61,883,306.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 20.88
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
-12 -16 -24 -56 193 -334 -565 -534 -309 -664 1,144
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -18.91% -7.52% -12.01% 15.54%
Earnings before Interest and Taxes (EBIT)
-17 -22 -35 -75 206 -478 -807 -763 -447 -74 1,120
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-16 -22 -34 -75 208 -474 -801 -659 -335 -57 1,148
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 15 -234 -163 -324 27 -1,297 -1,314 -259 -2,614 1,300
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.21 -31 179 287 803 442 1,175 1,955 1,905 3,855 3,742
Increase / (Decrease) in Invested Capital
0.00 -31 210 107 517 -361 732 781 -51 1,950 -156
Book Value per Share
($3.10) ($3.52) ($4.18) ($4.80) $11.57 ($15.55) ($19.52) ($27.51) ($28.05) ($7.61) $18.71
Tangible Book Value per Share
($3.10) ($3.52) ($4.18) ($4.81) $10.32 ($19.46) ($23.13) ($30.73) ($30.31) ($10.68) $14.23
Total Capital
41 67 414 616 1,927 1,680 2,542 2,823 4,113 5,531 7,359
Total Debt
0.00 0.00 0.00 0.00 5.10 6.18 7.96 9.01 15 33 36
Total Long-Term Debt
0.00 0.00 0.00 0.00 5.10 6.18 7.96 9.01 15 33 36
Net Debt
-39 -95 -232 -324 -367 -1,211 -1,327 -793 -2,043 -1,477 -3,458
Capital Expenditures (CapEx)
0.00 0.91 0.42 0.78 47 0.00 121 0.84 0.00 1.80 6.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.07 -22 180 286 991 512 907 1,671 1,652 2,713 2,088
Debt-free Net Working Capital (DFNWC)
39 73 411 609 1,363 1,729 2,242 2,472 3,701 4,213 5,579
Net Working Capital (NWC)
39 73 411 609 1,363 1,729 2,242 2,472 3,701 4,213 5,579
Net Nonoperating Expense (NNE)
4.91 6.69 9.57 21 12 274 -157 176 -14 -1,497 -148
Net Nonoperating Obligations (NNO)
-40 -98 -235 -330 -1,118 -1,232 -1,359 -858 -2,193 -1,643 -3,581
Total Depreciation and Amortization (D&A)
0.21 0.35 0.52 0.56 2.43 3.92 5.87 104 111 18 28
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($13.05) ($5.16) $13.92 $21.08
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 32.18M 35.98M 42.76M 47.57M 0.00 55.40M 59.19M 60.76M 61.88M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($13.05) ($5.16) $12.78 $19.57
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 32.18M 35.98M 42.76M 47.57M 0.00 55.40M 59.19M 60.76M 61.88M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 24.61M 33.42M 38.62M 45.41M 0.00 54.38M 57.17M 59.86M 61.30M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -16 -24 -56 193 -334 -565 -534 -309 -47 792
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for argenex

No quarterly metrics and ratios for argenex are available.



Financials Breakdown Chart

Frequently Asked Questions About argenex's Financials

When does argenex's financial year end?

According to the most recent income statement we have on file, argenex's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has argenex's net income changed over the last 10 years?

argenex's net income appears to be on an upward trend, with a most recent value of $1.29 billion in 2025, falling from -$16.64 million in 2015. The previous period was $833.04 million in 2024. Find out what analysts predict for argenex in the coming months.

What is argenex's operating income?
argenex's total operating income in 2025 was $1.13 billion, based on the following breakdown:
  • Total Gross Profit: $3.86 billion
  • Total Operating Expenses: $2.73 billion
How has argenex's revenue changed over the last 10 years?

Over the last 10 years, argenex's total revenue changed from $11.01 million in 2015 to $4.31 billion in 2025, a change of 39,069.7%.

How much debt does argenex have?

argenex's total liabilities were at $1.36 billion at the end of 2025, a 93.1% increase from 2024, and a 14,309.4% increase since 2015.

How much cash does argenex have?

In the past 10 years, argenex's cash and equivalents has ranged from $38.59 million in 2015 to $3.49 billion in 2025, and is currently $3.49 billion as of their latest financial filing in 2025.

How has argenex's book value per share changed over the last 10 years?

Over the last 10 years, argenex's book value per share changed from -3.10 in 2015 to 18.71 in 2025, a change of -703.4%.



Financial statements for NASDAQ:ARGX last updated on 3/24/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners